Point72 Hong Kong Ltd - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 12 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$4,000
-92.0%
357
-90.5%
0.00%
-100.0%
Q2 2022$50,000
-54.1%
3,760
+4.8%
0.00%
-50.0%
Q3 2021$109,000
+373.9%
3,589
+577.2%
0.00%
+300.0%
Q1 2021$23,000
-73.9%
530
-74.0%
0.00%
-88.9%
Q3 2020$88,000
+300.0%
2,036
+33.2%
0.01%
+80.0%
Q4 2019$22,000
+340.0%
1,528
+113.7%
0.01%
+400.0%
Q3 2019$5,000
+66.7%
715
+59.6%
0.00%0.0%
Q3 2018$3,000
-25.0%
4480.0%0.00%0.0%
Q2 2018$4,000
-93.7%
448
-92.8%
0.00%
-96.9%
Q1 2018$63,0006,1990.03%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 60,000$151,8000.16%
XTX Topco Ltd 33,605$85,0210.02%
Beacon Pointe Advisors, LLC 301,735$763,3900.01%
AllSquare Wealth Management LLC 4,527$11,4530.01%
Virtus ETF Advisers LLC 4,646$11,7540.01%
Y-Intercept (Hong Kong) Ltd 27,553$69,7090.01%
SeaCrest Wealth Management, LLC 16,550$41,8720.01%
Hennion & Walsh Asset Management, Inc. 33,940$85,8680.01%
Cutler Group LLC / CA 4,000$500.01%
Capital Investment Advisory Services, LLC 17,991$45,5170.00%
View complete list of BIOXCEL THERAPEUTICS INC shareholders